Lack of CD44 variant 6 expression in advanced extrahepatic bile duct/ampullary carcinoma

Cancer

Volumn 86, Issue 9, 1999, Pages 1691-1699

  Yokoyama, Yujiro ^a   Hiyama, Eiso ^a   Murakami, Yoshiaki ^a   Matsuura, Yuichiro ^a   Yokoyama, Takashi ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Ampulla of Vater; Cancer; CD44; Extrahepatic bile duct; Lymph node metastases; Prognosis

Indexed keywords

CD44 V6 ANTIGEN; CD44V ANTIGEN; HERMES ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ANTIGEN EXPRESSION; ARTICLE; BILE DUCT CARCINOMA; CANCER GROWTH; CANCER INVASION; CELL INTERACTION; CLINICAL ARTICLE; FEMALE; HUMAN; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROGNOSIS; VATER PAPILLA CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; AMPULLA OF VATER; ANTIGENS, CD44; BILE DUCT NEOPLASMS; BILE DUCTS, EXTRAHEPATIC; CELL ADHESION; COMMON BILE DUCT NEOPLASMS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL RATE;

EID: 0033229729     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19991101)86:9<1691::AID-CNCR10>3.0.CO;2-Z     Document Type: Article

References (29)

1. Shino Y, Watanabe A, Yamada Y, Tanase M, Yamada T, Matsuda M, et al. Clinicopathologic evaluation of immunohistochemical E-cadherin expression in human gastric carcinomas. Cancer 1995;76:2193-201.
2. Dong JT, Suzuki H, Pin SS, Bova GS, Schalken JA, Isaacs WB, et al. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. Cancer Res 1996;56:4387-90.
3. Yao M, Zhou XD, Zha XL, Shi DR, Fu J, He JY, et al. Expression of the integrin alpha 5 subunit and its mediated cell adhesion in hepatocellular carcinoma. J Cancer Res Clin Oncol 1997;123:435-40.
4. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992;89:12160-4.
5. Tempfer C, Losch A, Heinzl H, Hausler G, Hanzal E, Kolbl H, et al. Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancer. Eur J Cancer 1996;32a:2023-5.
6. Nishimura S, Chung YS, Yashiro M, Inoue T, Sowa M. CD44H plays an important role in peritoneal dissemination of scirrhous gastric cancer cells. Jpn J Cancer Res 1996;87: 1235-44.
7. Stauder R, Van Driel M, Schwarzler C, Thaler J, Lokhorst HM, Kreuser ED, et al. Different CD44 splicing patterns define prognostic subgroups in multiple myeloma. Blood 1996;88:3101-8.
8. Nihei Z, Ichikawa W, Kojima K, Togo S, Miyanaga T, Hirayama R, et al. The positive relationship between the expression of CD44 variant 6 and prognosis in colorectal cancer. Surg Today 1996;26:760-1.
9. Tanabe KK, Stamenkovic I, Cutler M, Takahashi K. Restoration of CD44H expression in colon carcinomas reduces tumorigenicity. Ann Surg 1995;222:493-503.
10. Kan M, Aki M, Akiyama K, Naruo S, Kanayama H, Kagawa S. High-level expression of the CD44 variant sharing exon v10 in renal cancer. Jpn J Cancer Res 1995;86:847-53.
11. Tempfer C, Gitsch G, Haeusler G, Reinthaller A, Koelbl H, Kainz C. Prognostic value of immunohistochemically detected CD44 expression in patients with carcinoma of the vulva. Cancer 1996;78:273-7.
12. Sugino T, Gorham H, Yoshida K, Bolodeoku J, Nargund V, Cranston D, et al. Progressive loss of CD44 gene expression in invasive bladder cancer. Am J Pathol 1996;149:873-82.
13. Kallakury BV, Yang F, Figge J, Smith KE, Kausik SJ, Tacy NJ, et al. Decreased levels of CD44 protein and mRNA in prostate carcinoma. Correlation with tumor grade and ploidy. Cancer 1996;78:1461-9.
14. Cannistra SA, Kansas GS, Niloff J, DeFranzo B, Kim Y, Ottensmeier C. Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H. Cancer Res 1993;53:3830-8.
15. Gross N, Beck D, Beretta C, Jackson D, Perruisseau G. CD44 expression and modulation on human neuroblastoma tumours and cell lines. Eur J Cancer 1995;31a:471-5.
16. Combaret V, Gross N, Lasset C, Frappaz D, Peruisseau G, Philip T, et al. Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas. J Clin Oncol 1996; 14:25-34.
17. Fujita N, Yaegashi N, Ide Y, Sato S, Nakamura M, Ishiwata I, et al. Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells. Cancer Res 1994;54:3922-8.
18. Kunishi M, Kayada Y, Yoshiga K. Down-regulated expression of CD44 variant 6 in oral squamous cell carcinomas and its relationship to regional lymph node metastasis. Int J Oral Maxillofac Surg 1997;26:280-3.
19. Hermanek P, Sobin L. International Union Against Cancer TNM classification of malignant tumours. 5th ed. Berlin: Springer-Verlag, 1997.
20. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
21. Stamenkovic I, Amiot M, Pesando JM, Seed B. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 1989;56:1057-62.
22. Hofmann M, Rudy W, Zoller M, Tolg C, Ponta H, Herrlich P, et al. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res 1991;51:5292-7.
23. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
24. Kurosaki I, Tsukada K, Hatakeyama K, Muto T. The mode of lymphatic spread in carcinoma of the bile duct. Am J Surg 1996;172:239-43.
25. Kayahara M, Nagakawa T, Ohta T, Kitagawa H, Miyazaki I. Surgical strategy for carcinoma of the papilla of Vater on the basis of lymphatic spread and mode of recurrence. Surgery 1997;121:611-7.
26. Pichlmayr R, Weimann A, Klempnauer J, Oldhafer KJ, Maschek H, Tusch G, et al. Surgical treatment in proximal bile duct cancer. A single-center experience. Ann Surg 1996;224: 628-38.
27. Talamini MA, Moesinger RC, Pitt HA, Sohn TA, Hruban RH, Lillemoe KD, et al. Adenocarcinoma of the ampulla of Vater. A 28-year experience. Ann Surg 1997;225:590-600.
28. Ashida K, Terada T, Kitamura Y, Kaibara N. Expression of E-cadherin, alpha-catenin, beta-catenin, and CD44 (standard and variant isoforms) in human cholangiocarcinoma: an immunohistochemical study. Hepatology 1998;27:974-82.
29. Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s. Ann Surg 1997;226:248-60.